Singapore’s health authority said on Monday it was in talks with AstraZeneca about its coronavirus vaccine and had sought more information from Sinovac Biotech prior to using the vaccine for its immunisation drive.

Many Asian countries are now accelerating the rollout of AstraZeneca’s vaccine despite a brief scare in Europe, where many countries temporarily halted its deployment over reports that it was linked to blood clotting.

“The Health Sciences Authority (HSA) had been in communication with various companies including AstraZeneca on their submission plans for COVID-19 vaccines,” the authority said in a statement, adding that all vaccines are rigorously evaluated.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook